Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-08-13 00:44:39 UTC |
---|
Updated at | 2024-09-17 15:42:23 UTC |
---|
NP-MRD ID | NP0000601 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Scopolamine |
---|
Description | Scopolamine, also known as hyoscine, is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. Scopolamine is used criminally as a date rape drug and as an aid to robbery, the most common act being the clandestine drugging of a victim's drink. It is preferred because it induces retrograde amnesia, or an inability to recall events prior to its administration. Victims of this crime are often admitted to a hospital in police custody, under the assumption that the patient is experiencing a psychotic episode. A telltale sign is a fever accompanied by a lack of sweat. An alkaloid from Solanaceae, especially Datura metel L. And Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. |
---|
Structure | CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Hyoscine | ChEBI | (-)-Scopolamine | ChEBI | (1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate | ChEBI | 6,7-Epoxytropine tropate | ChEBI | 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate | ChEBI | alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester | ChEBI | Hyoscine | ChEBI | Scopine (-)-tropate | ChEBI | Transderm-scop | ChEBI | (1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoic acid | Generator | 6,7-Epoxytropine tropic acid | Generator | 6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropate | Generator | 6-b,7-b-Epoxy-3-a-tropanyl S-(-)-tropic acid | Generator | 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropic acid | Generator | 6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropate | Generator | 6-Β,7-β-epoxy-3-α-tropanyl S-(-)-tropic acid | Generator | a-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester | Generator | a-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester | Generator | alpha-(Hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester | Generator | Α-(hydroxymethyl)benzeneacetate 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester | Generator | Α-(hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester | Generator | Scopine (-)-tropic acid | Generator | (+)-Hyoscine | HMDB | (+)-Scopolamine | HMDB | (-)-Hyoscine hydrobromide | HMDB | (-)-Scopolamine bromide | HMDB | (-)-Scopolamine hydrobromide | HMDB | Atrochin | HMDB | Atroquin | HMDB | Beldavrin | HMDB | Buscopan | HMDB | Epoxytropine tropate | HMDB | Euscopol | HMDB | Hydroscine hydrobromide | HMDB | Hyosceine | HMDB | Hyoscine bromide | HMDB | Hyoscine hydrobromide | HMDB | Hyoscyine hydrobromide | HMDB | Hyosol | HMDB | Hysco | HMDB | Isopto hyoscine | HMDB | Isoscopil | HMDB | Kwells | HMDB | L-Hyoscine hydrobromide | HMDB | L-Scopolamine-hydrobromide | HMDB | Methscopolamine bromide | HMDB | Oscine | HMDB | Pamine | HMDB | S-(-)-Tropate | HMDB | Scop | HMDB | Scopamin | HMDB | Scopine tropate | HMDB | Scopolamine bromide | HMDB | Scopolamine hydrobromide | HMDB | Scopolaminium bromide | HMDB | Scopolammonium bromide | HMDB | SEE | HMDB | Tranaxine | HMDB | Norhyoscine | HMDB | 6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate | HMDB | 6Β,7β-epoxy-3α-tropanyl S-(-)-tropate | HMDB | 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol (-)-tropate | HMDB | L-Scopolamine | HMDB | (-)-Atropine | HMDB | (-)-Hyoscyamine | HMDB | (S)-(-)-Hyoscyamine | HMDB | (S)-Atropine | HMDB | 1AlphaH,5alphah-tropan-3alpha-yl (-)-tropate | HMDB | 1ΑH,5αh-tropan-3α-yl (-)-tropate | HMDB | Cystospaz | HMDB | Daturine | HMDB | Duboisine | HMDB | Hyoscyamine | HMDB | L-Hyoscyamin | HMDB | L-Hyoscyamine | HMDB | L-Atropine | HMDB | L-Tropine tropate | HMDB | (±)-atropine | HMDB | (±)-hyoscyamine | HMDB | Atropin | HMDB | Atropine | HMDB | Atropinum sulfuricum | HMDB | Atropinum sulphuricum | HMDB | DL-Hyoscyamine | HMDB | Tropine (±)-tropate | HMDB | Tropine tropate | HMDB | DL-Tropyl tropate | HMDB |
|
---|
Chemical Formula | C17H21NO4 |
---|
Average Mass | 303.3529 Da |
---|
Monoisotopic Mass | 303.14706 Da |
---|
IUPAC Name | (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate |
---|
Traditional Name | (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate |
---|
CAS Registry Number | 51-34-3 |
---|
SMILES | CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1 |
---|
InChI Key | STECJAGHUSJQJN-FWXGHANASA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Hydroxy acids and derivatives |
---|
Sub Class | Beta hydroxy acids and derivatives |
---|
Direct Parent | Beta hydroxy acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Beta-hydroxy acid
- Monocyclic benzene moiety
- Morpholine
- Oxazinane
- Piperidine
- N-alkylpyrrolidine
- Benzenoid
- Pyrrolidine
- Amino acid or derivatives
- Carboxylic acid ester
- Tertiary amine
- Tertiary aliphatic amine
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Dialkyl ether
- Oxirane
- Ether
- Monocarboxylic acid or derivatives
- Primary alcohol
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Amine
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 59 °C | Not Available | Boiling Point | 188.10 °C. @ 760.00 mm Hg | The Good Scents Company Information System | Water Solubility | 100 mg/mL | Not Available | LogP | 0.98 | Sangster, J. (1993). LOGKOW- a Databank of Evaluated Octanol-Water Partition Coefficients. Sangster Research Laboratories, Montreal. |
|
---|
Predicted Properties | |
---|
General References | - Lee HW, Park WS, Kim YW, Cho SH, Kim SS, Seo JH, Lee KT: A rapid and sensitive liquid chromatography/positive ion tandem mass spectrometry method for the determination of cimetropium in human plasma by liquid-liquid extraction. J Mass Spectrom. 2006 Jul;41(7):855-60. [PubMed:16810649 ]
- Blin J, Piercey MF, Giuffra ME, Mouradian MM, Chase TN: Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. J Neurol Sci. 1994 May;123(1-2):44-51. [PubMed:8064320 ]
- Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW: In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab. 1992 Jan;12(1):147-54. [PubMed:1727135 ]
- Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH: The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2002 Jul;95(1):133-43, table of contents. [PubMed:12088957 ]
- Hagemann K, Piek K, Stockigt J, Weiler EW: Monoclonal antibody-based enzyme immunoassay for the quantitative determination of the tropane alkaloid, scopolamine. Planta Med. 1992 Feb;58(1):68-72. [PubMed:1620747 ]
- Boumba VA, Mitselou A, Vougiouklakis T: Fatal poisoning from ingestion of Datura stramonium seeds. Vet Hum Toxicol. 2004 Apr;46(2):81-2. [PubMed:15080209 ]
- Rosier A, Cornette L, Orban GA: Scopolamine-induced impairment of delayed recognition of abstract visual shapes. Neuropsychobiology. 1998;37(2):98-103. [PubMed:9566275 ]
- Smith AM, Cadoret G, St-Amour D: Scopolamine increases prehensile force during object manipulation by reducing palmar sweating and decreasing skin friction. Exp Brain Res. 1997 May;114(3):578-83. [PubMed:9187293 ]
- Ebert U, Grossmann M, Oertel R, Gramatte T, Kirch W: Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. J Clin Pharmacol. 2001 Jan;41(1):51-60. [PubMed:11144994 ]
- Renner UD, Oertel R, Kirch W: Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit. 2005 Oct;27(5):655-65. [PubMed:16175141 ]
- Gordon C, Ben-Aryeh H, Attias J, Szargel R, Gutman D: Effect of transdermal scopolamine on salivation. J Clin Pharmacol. 1985 Sep;25(6):407-12. [PubMed:4056076 ]
- Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, Geng M: Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett. 2005 Feb 21;374(3):222-6. Epub 2004 Dec 10. [PubMed:15663967 ]
- Stetina PM, Madai B, Kulemann V, Kirch W, Joukhadar C: Pharmacokinetics of scopolamine in serum and subcutaneous adipose tissue in healthy volunteers. Int J Clin Pharmacol Ther. 2005 Mar;43(3):134-9. [PubMed:15792397 ]
- Schwarz RD, Callahan MJ, Coughenour LL, Dickerson MR, Kinsora JJ, Lipinski WJ, Raby CA, Spencer CJ, Tecle H: Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization. J Pharmacol Exp Ther. 1999 Nov;291(2):812-22. [PubMed:10525104 ]
- Suojaranta-Ylinen R, Hendolin H, Tuomisto L: The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumption. Agents Actions. 1991 May;33(1-2):212-4. [PubMed:1897441 ]
- Dreyfuss P, Vogel D, Walsh N: The use of transdermal scopolamine to control drooling. A case report. Am J Phys Med Rehabil. 1991 Aug;70(4):220-2. [PubMed:1878183 ]
- Putcha L, Cintron NM, Tsui J, Vanderploeg JM, Kramer WG: Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res. 1989 Jun;6(6):481-5. [PubMed:2762223 ]
|
---|